Blood Gas and Electrolyte Analyzers Market is registering a CAGR of 5.7% from 2017 to 2023

North America is expected to dominate the global blood gas and electrolyte analyzer market during the forecast period.

North America is expected to dominate the global blood gas and electrolyte analyzer market during the forecast period. However, the market is growing at a faster rate in the developing countries, owing to the increase in the number of patients suffering from chronic diseases and improvement in the healthcare facilities.

The global blood gas and electrolyte analyzers market was valued at $1,427 million in 2016, and is projected to garner $2,104 million by 2023, registering a CAGR of 5.7% from 2017 to 2023. 

In detail along with the table of contents, please click on the link below:

https://www.alliedmarketresearch.com/request-sample/4608

Blood gas analyzers are used to measure different parameters, such as pH, blood gas (pCO2 and pO2), electrolytes, and metabolites, from the whole blood samples. Growth in number of patients being treated in ICUs, NICUs, and emergency departments; rise in number of patients suffering from chronic diseases; technological advancement in blood gas & electrolyte analyzers, and increase in number of product approvals are the major factors driving the market growth. However, complexity involved in the interpretation of data act as a restraining factor for the market growth. Increase in investment by major medical diagnostics giants and improvement in healthcare facilities in Asia-Pacific provides growth opportunities for the market.

Key Findings of the Blood Gas and Electrolyte Analyzers Market

  • In 2016, the portable analyzer segment accounted for the highest share of the global blood gas & electrolyte analyzers market.
  • The ABL Flex segment contributed the highest revenue to the global market in 2016.
  • The hospital segment is projected to grow at the highest CAGR of 5.9% during the forecast period.
  • North America market is projected to grow at a CAGR of 4.4% from 2017 to 2023.

Based on product/brand, it is classified into i-STAT, GEM Premier, ABL Flex, RAPID series, Cobas, and other blood gas analyzers. The ABL Flex segment holds the highest share in the global market, as it offers wide range of products ranging from portable to benchtop blood gas analyzers. Based on end user, it is categorized into hospitals, clinics, ambulatory surgical centers, and others. Hospitals hold the highest market share in the global market, owing to the rise in number of patients treated in ICUs, NICUs, and emergency departments, where the utilization of blood gas analyzers is high to treat patients in critical conditions.

Geographically, North America dominated the global market in 2016, and is estimated to continue its dominance during the forecast period. This is attributed to higher adoption for technologically advanced devices, well-equipped healthcare facilities, and rise in admission of patients in ICUs, NICUs, and emergency departments.

Connect Analyst:

https://www.alliedmarketresearch.com/connect-to-analyst/388

Leading market players

  • Instrumentation Laboratory (A Werfen Company) (U.S.)
  • Siemens AG (Germany)
  • Roche Diagnostics Limited (Switzerland)
  • Abbott Laboratories, Inc. (U.S.)
  • Nova Biomedical (U.S.)
  • OPTI Medical Systems, Inc. (A Subsidiary of Idexx Laboratories, Inc.) (U.S.)
  • ERBA Diagnostics Mannheim GmbH (Germany)
  • Medica Corporation (U.S.)
  • Alere, Inc. (U.S.)

Allied Market Research Coverage on the Healthcare Domain

Micromanipulators Market  By Type (Hydraulic, Electric, Manual) and By Application (Embryonic stem cell transfer, Intra-cytoplasmic sperm injection (ICSI), Pronuclear zygote injection, Embryo reconstruction, Microsurgical, Biopsy, Industrial Micromanipulation, microelectronics, Flat screens, packaged parts and probing functions, drug discovery) - Global Opportunity Analysis and Industry Forecast, 2021 – 2028

Liver Disease Treatment Market by Treatment Type (Anti-Rejection Drugs/Immunosupressants, Chemotherapy Drugs, Targeted therapy, Vaccines, Anti-Viral Drugs, IImmunoglobulins, Corticosteroids) - Global Opportunity Analysis and Industry Forecast, 2020 - 2027

 

About Us:

Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.
 

We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.


Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1(855)550-5975
help@alliedmarketresearch.com